StonvexLoading…
StonvexCore line items from PVH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q2 2026 (Est.) Expected 2026-06-02 | Annual 2026 2026-02-01 | Q4 2025 2025-11-02 | Q3 2025 2025-08-03 | Q2 2025 2025-05-04 |
|---|---|---|---|---|---|
Revenue | $2.02B | $8.95B | $6.45B | $4.15B | $1.98B |
Operating Income | Not available | $230.60M | $-18.20M | $-199.00M | $-332.20M |
Net Income | Not available | $25.30M | $183.60M | $224.20M | $-44.80M |
EPS (Diluted) | $1.89 | $0.52 | $3.72 | $3.59 | $-0.88 |
Total Assets | Not available | $11.68B | $11.42B | $11.63B | $10.67B |
Total Liabilities | Not available | Not available | Not available | Not available | Not available |
Cash & Equivalents | Not available | $701.50M | $158.20M | $248.80M | $191.00M |
Free Cash Flow OCF − CapEx | Not available | $538.40M | $-1.30M | $83.80M | $-98.10M |
Shares Outstanding | Not available | 48.50M | 49.30M | 50.00M | 51.10M |